Ambrisentan degradation product and preparation method thereof

A degradation product, ambrisentan technology, applied in the field of biomedicine, can solve the problems of undisclosed degradation products, unknown structure, etc.

Active Publication Date: 2014-12-03
SHANGHAI MEIYUE BIOTECH DEV +1
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The study found that ambrisentan will undergo a small amount of degradation to produce a degradation product, but the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ambrisentan degradation product and preparation method thereof
  • Ambrisentan degradation product and preparation method thereof
  • Ambrisentan degradation product and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1 Preparation of ambrisentan degradation product I

[0013]

[0014] Sodium hydride (3.5 g, 0.08 mol) was added to 50 mL of DMF solution, under nitrogen protection, cooled to 0~5 degrees, and then 2,2-diphenylacetaldehyde (5 g, 0.026 mol ) in DMF was added dropwise (50 mL) solution, maintain the temperature at 0~5 degrees, continue to stir the reaction for 0.5 h after the drop, and then add dropwise 4,6-dimethyl-2-methylsulfonylpyrimidine (5.2 g, 0.028 mol ) in DMF (50 mL) solution, continue to stir for 2 h after dripping, TLC detects that the reaction is complete, pour the reaction solution into 200 mL of ice-water mixture, filter, wash the filter cake with water (30 ml x 3) for 3 times, and then vacuum-dry to obtain a 8 g of white solid is the degradation product I of ambrisentan.

[0015] Mass Spectrum (ESI): m / z 303.1 (M+H) + .

[0016] 1 H NMR (400 MHz, CDCl 3 ) δ: 7.91 (s, 1H), 7.43 (d, J = 8 Hz, 2H), 7.35 ~ 7.25 (m, 8H), 6.78 (s, 1H), 2.44 (s, 6...

Embodiment 2

[0018] Example 2 Separation and detection of ambrisentan degradation product I

[0019] HPLC conditions:

[0020] Octadecylsilane-bonded silica gel was used as filler, mobile phase A was 0.01 mol / L dipotassium hydrogen phosphate buffer (phosphoric acid adjusted to pH 4.5), mobile phase B was acetonitrile, and the gradient elution was as follows Table 1 For elution, the detection wavelength is 210 nm, and the column temperature is 30 °C. The theoretical plate number should not be less than 5000 based on the calculation of Anlishengtan peak.

[0021] Gradient elution table 1

[0022] time (min) Mobile phase A (%) Mobile phase B (%) 0 90 10 3 90 10 13 35 65 40 35 65

[0023] Take an appropriate amount of impurity I and ambrisentan respectively, dilute with acetonitrile to prepare 0.5 mg / mL, inject 20 μL each into the sample, and separate and detect under the above HPLC conditions.

[0024] Analysis results: The HPLC chart of Ambrisent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an ambrisentan degradation product and a preparation method thereof. The ambrisentan degradation product is represented by formula I, is one of main impurities of ambrisentan raw materials or preparations thereof and the formula I can be used for analyzing the purity of ambrisentan, and can also be used for controlling the quality of ambrisentan. The preparation method of the product of the formula I is characterized in that a substitution reaction of 2,2-diphenyl acetaldehyde and a compound represented by formula II is carried out under the action of sodium hydride and other alkaline compounds.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a degradation product of ambrisentan and a preparation method thereof. Background technique [0002] Ambrisentan is an endothelin receptor antagonist (ERA) originally developed by Abbott of the United States, and Myogen Corporation of the United States has acquired its global development and marketing rights. Subsequently, GlaxoSmithKline (Glaxosmithkline) of the United States signed an agreement with Myogen to obtain the production rights of this product outside the United States. On November 17, 2006, Gilead Science of the United States acquired Myogen as a subsidiary company and obtained the ownership of Ambrisentan. The drug was approved by the US FDA on June 15, 2007. The trade name is Letairis. It is used orally for the treatment of pulmonary arterial hypertension (PAH). The chemical name is (+)-(2S)-2-[(4,6-two Methylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D239/34
CPCC07D239/34
Inventor 朱高军袁洪顺刘勇潘新王朝东
Owner SHANGHAI MEIYUE BIOTECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap